{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:03:55Z","timestamp":1792029835815,"version":"4.4.0"},"reference-count":152,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ajpc.2026.101445","type":"journal-article","created":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T06:54:08Z","timestamp":1769324048000},"page":"101445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["iCARDIO Alliance global implementation guidelines for the management of obesity 2025 focus on prevention and treatment of cardiometabolic disease"],"prefix":"10.1016","volume":"27","author":[{"given":"Stefan D.","family":"Anker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy","family":"Kindel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.S.","family":"Coats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dike","family":"Ojji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Puente","family":"Barrag\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Zieroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaaf","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shariq","family":"Usman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeta","family":"Appannah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison L.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Bennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Brandao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie J.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubomira","family":"Fabryova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Lin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday M.","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carel W.","family":"Le Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto J.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Rosenstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banshi","family":"Saboo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Sabbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangesh","family":"Tiwaskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol E.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang Wei","family":"Tham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Stuardo","family":"Wyss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter P.","family":"Abhayaratna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael Al","family":"Mahmeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Argir\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Atherton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Belardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Campuzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Andr\u00e9","family":"Cornier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemencia de Rueda","family":"Panadero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastase","family":"Dzudie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ty J.","family":"Gluckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Shahzeb","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Lopatin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okechukwu S.","family":"Ogah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Oomman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio S.","family":"Peralta Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Redfern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe M.C.","family":"Rosano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Saraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameh","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subodh","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"von Haehling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Zamorano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpc.2026.101445_bib0001","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2026.101445_bib0002","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1016\/S2468-2667(18)30021-5","article-title":"Prevalence trends tell us what did not precipitate the US obesity epidemic","volume":"3","author":"Rodgers","year":"2018","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.ajpc.2026.101445_bib0003","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.3390\/nu14204253","article-title":"The origins of the obesity epidemic in the USA-Lessons for today","volume":"14","author":"Temple","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.ajpc.2026.101445_bib0004","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ajpc.2026.101445_bib0005","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s13167-021-00251-4","article-title":"Caution, \"normal\" BMI: health risks associated with potentially masked individual underweight-EPMA Position Paper 2021","volume":"12","author":"Golubnitschaja","year":"2021","journal-title":"EPMA J"},{"key":"10.1016\/j.ajpc.2026.101445_bib0006","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(25)00355-1","article-title":"Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021","volume":"405","author":"Ng","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2026.101445_bib0007","first-page":"354","article-title":"Direct medical costs of obesity in the United States and the most populous states","volume":"27","author":"Cawley","year":"2021","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.ajpc.2026.101445_bib0008","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1467-789X.2009.00708.x","article-title":"Direct medical cost of overweight and obesity in the USA: a quantitative systematic review","volume":"12","author":"Tsai","year":"2011","journal-title":"Obes Rev"},{"key":"10.1016\/j.ajpc.2026.101445_bib0009","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2022-009773","article-title":"Economic impacts of overweight and obesity: current and future estimates for 161 countries","volume":"7","author":"Okunogbe","year":"2022","journal-title":"BMJ Global Health"},{"key":"10.1016\/j.ajpc.2026.101445_bib0010","first-page":"51s","article-title":"Clinical Guidelines on the identification, evaluation, and treatment of overweight and obesity in adults\u2013The evidence report","volume":"6","year":"1998","journal-title":"National Institutes of Health. Obes Res"},{"key":"10.1016\/j.ajpc.2026.101445_bib0011","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.4158\/EP161365.GL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ajpc.2026.101445_bib0012","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC)","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2026.101445_bib0013","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2022.08.045","article-title":"AGA clinical practice guideline on pharmacological interventions for adults with obesity","volume":"163","author":"Grunvald","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpc.2026.101445_bib0014","first-page":"450","article-title":"Guidelines for medical nutrition treatment of overweight\/obesity in China (2021)","volume":"31","year":"2022","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.1016\/j.ajpc.2026.101445_bib0015","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.2337\/dc24-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajpc.2026.101445_bib0016","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2026.101445_bib0017","first-page":"e596","article-title":"2019 ACC\/AHA Guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2026.101445_bib0018","doi-asserted-by":"crossref","first-page":"E1460","DOI":"10.1503\/cmaj.220138","article-title":"Canadian Cardiovascular Harmonized National Guideline Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2022 update","volume":"194","author":"Jain","year":"2022","journal-title":"CMAJ"},{"key":"10.1016\/j.ajpc.2026.101445_bib0019","doi-asserted-by":"crossref","first-page":"482","DOI":"10.5694\/mja2.52280","article-title":"2023 Australian guideline for assessing and managing cardiovascular disease risk","volume":"220","author":"Nelson","year":"2024","journal-title":"Med J Aust"},{"key":"10.1016\/j.ajpc.2026.101445_bib0020","doi-asserted-by":"crossref","first-page":"s117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 Clinical Practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajpc.2026.101445_bib0021","first-page":"e13","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ajpc.2026.101445_bib0022","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"10.1016\/j.ajpc.2026.101445_bib0023","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","volume":"28","author":"Cusi","year":"2022","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ajpc.2026.101445_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2021.108101","article-title":"DCRM: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases","volume":"36","author":"Handelsman","year":"2022","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.ajpc.2026.101445_bib0025","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2026.101445_bib0026","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.hlc.2018.06.1042","article-title":"National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018","volume":"27","author":"Atherton","year":"2018","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.ajpc.2026.101445_bib0027","doi-asserted-by":"crossref","first-page":"E875","DOI":"10.1503\/cmaj.191707","article-title":"Obesity in adults: a clinical practice guideline","volume":"192","author":"Wharton","year":"2020","journal-title":"CMAJ"},{"key":"10.1016\/j.ajpc.2026.101445_bib0028","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jacc.2025.05.024","article-title":"2025 concise clinical guidance: An ACC expert consensus statement on medical weight management for optimization of cardiovascular health: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"86","author":"Gilbert","year":"2025","journal-title":"J Am Coll Cardio"},{"key":"10.1016\/j.ajpc.2026.101445_bib0029","article-title":"Barriers and enablers to implementing clinical practice guidelines in primary care: an overview of systematic reviews","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajpc.2026.101445_bib0030","doi-asserted-by":"crossref","first-page":"590","DOI":"10.5604\/12321966.1120608","article-title":"Obesity and poverty paradox in developed countries","volume":"21","author":"\u017bukiewicz-Sobczak","year":"2014","journal-title":"Ann Agric Environ Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0031","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: A scientific statement from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2026.101445_bib0032","unstructured":"U.S. Food and Drug Administration. FDA Approves first treatment to reduce risk of serious heart problems specifically in adults with obesity or overweight. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-reduce-risk-serious-heart-problems-specifically-adults-obesity-or."},{"key":"10.1016\/j.ajpc.2026.101445_bib0033","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S2213-8587(21)00088-7","article-title":"Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study","volume":"9","author":"Caleyachetty","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ajpc.2026.101445_bib0034","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41591-020-0803-x","article-title":"Joint international consensus statement for ending stigma of obesity","volume":"26","author":"Rubino","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0035","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.appet.2016.02.032","article-title":"The relationship between weight stigma and eating behavior is explained by weight bias internalization and psychological distress","volume":"102","author":"O'Brien","year":"2016","journal-title":"Appetite"},{"key":"10.1016\/j.ajpc.2026.101445_bib0036","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.appet.2016.01.034","article-title":"Weight stigma and eating behavior: A review of the literature","volume":"102","author":"Vartanian","year":"2016","journal-title":"Appetite"},{"key":"10.1016\/j.ajpc.2026.101445_bib0037","first-page":"27","article-title":"Clinical review: modified 5 As: minimal intervention for obesity counseling in primary care","volume":"59","author":"Vallis","year":"2013","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.ajpc.2026.101445_bib0038","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ijo.2008.11","article-title":"Accuracy of body mass index in diagnosing obesity in the adult general population","volume":"32","author":"Romero-Corral","year":"2008","journal-title":"Int J Obes (London)"},{"key":"10.1016\/j.ajpc.2026.101445_bib0039","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ajcn\/60.1.23","article-title":"Asians have lower body mass index (BMI) but higher percent body fat than do whites: comparisons of anthropometric measurements","volume":"60","author":"Wang","year":"1994","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ajpc.2026.101445_bib0040","unstructured":"World Health Organization. Waist circumference and waist\u2013hip ratio: report of a WHO expert consultation. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241501491."},{"key":"10.1016\/j.ajpc.2026.101445_bib0041","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/s41390-022-02223-4","article-title":"Diagnosis accuracy of waist-to-height ratio to predict cardiometabolic risk in children with obesity","volume":"93","author":"Mu\u00f1oz-Hernando","year":"2023","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ajpc.2026.101445_bib0042","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/met.2008.0102","article-title":"Index of central obesity is better than waist circumference in defining metabolic syndrome","volume":"7","author":"Parikh","year":"2009","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.ajpc.2026.101445_bib0043","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1467-789X.2002.00065.x","article-title":"Asians are different from Caucasians and from each other in their body mass index\/body fat per cent relationship","volume":"3","author":"Deurenberg","year":"2002","journal-title":"Obes Rev"},{"key":"10.1016\/j.ajpc.2026.101445_bib0044","doi-asserted-by":"crossref","first-page":"574","DOI":"10.2337\/dc12-0722","article-title":"Elevated rates of diabetes in Pacific Islanders and Asian subgroups: The Diabetes Study of Northern California (DISTANCE)","volume":"36","author":"Karter","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajpc.2026.101445_bib0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12902-022-01111-6","article-title":"Body fat assessment in youth with overweight or obesity by an automated bioelectrical impedance analysis device, in comparison with the dual-energy x-ray absorptiometry: a cross sectional study","volume":"22","author":"Samouda","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.ajpc.2026.101445_bib0046","doi-asserted-by":"crossref","first-page":"449S","DOI":"10.1093\/ajcn\/64.3.449S","article-title":"Limitations of the bioelectrical impedance method for the assessment of body fat in severe obesity","volume":"64","author":"Deurenberg","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ajpc.2026.101445_bib0047","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/oby.2005.146","article-title":"Air displacement plethysmography: validation in overweight and obese subjects","volume":"13","author":"Ginde","year":"2005","journal-title":"Obes Res"},{"key":"10.1016\/j.ajpc.2026.101445_bib0048","first-page":"19","article-title":"Obesity: lifestyle modification and behavior interventions","volume":"492","author":"Wilson","year":"2020","journal-title":"FP Essent"},{"key":"10.1016\/j.ajpc.2026.101445_bib0049","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1161\/01.cir.0000437739.71477.ee","article-title":"2013 AHA\/ACC\/TOS Guideline for the management of overweight and obesity in adults","volume":"129","author":"Jensen","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2026.101445_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/met.2010.0031","article-title":"Mediterranean diet and weight loss: meta-analysis of randomized controlled trials","volume":"9","author":"Esposito","year":"2011","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.ajpc.2026.101445_bib0051","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1017\/S0007114520001798","article-title":"Exploring the relationship between the Mediterranean diet and weight loss maintenance: the MedWeight study","volume":"124","author":"Poulimeneas","year":"2020","journal-title":"Br J Nutr"},{"key":"10.1016\/j.ajpc.2026.101445_bib0052","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/obr.12391","article-title":"The effect of dietary approaches to stop hypertension (DASH) diet on weight and body composition in adults: a systematic review and meta-analysis of randomized controlled clinical trials","volume":"17","author":"Soltani","year":"2016","journal-title":"Obes Rev"},{"key":"10.1016\/j.ajpc.2026.101445_bib0053","article-title":"The role of intermittent fasting on metabolic syndrome: a systematic review and meta-analysis","volume":"16","author":"Almabruk","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.ajpc.2026.101445_bib0054","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/ejcn.2012.37","article-title":"Effects of higher- versus lower-protein diets on health outcomes: a systematic review and meta-analysis","volume":"66","author":"Santesso","year":"2012","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.ajpc.2026.101445_bib0055","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/sj.ijo.0801453","article-title":"The role of low-fat diets in body weight control: a meta-analysis of ad libitum dietary intervention studies","volume":"24","author":"Astrup","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.ajpc.2026.101445_bib0056","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa0708681","article-title":"Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet","volume":"359","author":"Shai","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0057","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary Prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0058","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055030","article-title":"Low-carbohydrate diets and all-cause mortality: a systematic review and meta-analysis of observational studies","volume":"8","author":"Noto","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpc.2026.101445_bib0059","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12916-023-02869-9","article-title":"The effect of dietary carbohydrate and calorie restriction on weight and metabolic health in overweight\/obese individuals: a multi-center randomized controlled trial","volume":"21","author":"Sun","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0060","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3945\/ajcn.112.044321","article-title":"Effects of energy-restricted high-protein, low-fat compared with standard-protein, low-fat diets: a meta-analysis of randomized controlled trials","volume":"96","author":"Wycherley","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ajpc.2026.101445_bib0061","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13256","article-title":"Effect of exercise training on weight loss, body composition changes, and weight maintenance in adults with overweight or obesity: An overview of 12 systematic reviews and 149 studies","volume":"22","author":"Bellicha","year":"2021","journal-title":"Obes Rev"},{"key":"10.1016\/j.ajpc.2026.101445_bib0062","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1249\/MSS.0000000000001074","article-title":"Effects of weight loss on lean mass, strength, bone, and aerobic capacity","volume":"49","author":"Weiss","year":"2017","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.ajpc.2026.101445_bib0063","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1038\/sj.ijo.0803683","article-title":"A dose\u2013response relation between aerobic exercise and visceral fat reduction: systematic review of clinical trials","volume":"31","author":"Ohkawara","year":"2007","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.ajpc.2026.101445_bib0064","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.pcad.2018.07.014","article-title":"The effects of exercise and physical activity on weight loss and maintenance. progress in cardiovascular diseases","volume":"61","author":"Swift","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"issue":"1985","key":"10.1016\/j.ajpc.2026.101445_bib0065","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1152\/japplphysiol.01370.2011","article-title":"Effects of aerobic and\/or resistance training on body mass and fat mass in overweight or obese adults","volume":"113","author":"Willis","year":"2012","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.ajpc.2026.101445_bib0066","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/oby.2007.6","article-title":"Physical activity patterns in the National Weight Control Registry","volume":"16","author":"Catenacci","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.ajpc.2026.101445_bib0067","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1001\/archinte.168.14.1550","article-title":"Effect of exercise on 24-month weight loss maintenance in overweight women","volume":"168","author":"Jakicic","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0068","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0069","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A Randomized, controlled trial of 3.0 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0070","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ijo.2013.120","article-title":"Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE maintenance randomized study","volume":"37","author":"Wadden","year":"2013","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.ajpc.2026.101445_bib0071","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jama.2015.9676","article-title":"Efficacy of liraglutide for weight loss among patients with type 2 diabetes: The SCALE diabetes randomized clinical trial","volume":"314","author":"Davies","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2026.101445_bib0072","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ijo.2016.52","article-title":"Effect of liraglutide 3.0\u2009mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE sleep apnea randomized clinical trial","volume":"40","author":"Blackman","year":"2016","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.ajpc.2026.101445_bib0073","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1001\/jama.2016.7602","article-title":"Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis","volume":"315","author":"Khera","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2026.101445_bib0074","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(17)30069-7","article-title":"3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial","volume":"389","author":"le Roux","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2026.101445_bib0075","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2337\/ds16-0026","article-title":"Glucagon-like peptide 1 receptor agonists for type 2 diabetes","volume":"30","author":"Hinnen","year":"2017","journal-title":"Diabetes Spectr"},{"key":"10.1016\/j.ajpc.2026.101445_bib0076","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tcm.2021.12.008","article-title":"Semaglutide for the treatment of obesity","volume":"33","author":"Chao","year":"2023","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0077","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0078","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","article-title":"Semaglutide 2\u00b74 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial","volume":"397","author":"Davies","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2026.101445_bib0079","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jama.2021.1831","article-title":"Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial","volume":"325","author":"Wadden","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2026.101445_bib0080","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: The STEP 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2026.101445_bib0081","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/s41591-022-02026-4","article-title":"Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial","volume":"28","author":"Garvey","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0082","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/jama.2021.23619","article-title":"Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial","volume":"327","author":"Rubino","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2026.101445_bib0083","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJMoa2403664","article-title":"Once-weekly semaglutide in persons with obesity and knee osteoarthritis","volume":"391","author":"Bliddal","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0084","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(25)00226-8","article-title":"Once-weekly semaglutide 7.2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial","author":"Wharton","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ajpc.2026.101445_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(25)00225-6","article-title":"Once-weekly semaglutide 7.2 mg in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b trial","author":"Lingvay","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ajpc.2026.101445_bib0086","doi-asserted-by":"crossref","DOI":"10.2337\/dc25-1442","article-title":"Weight reduction with tirzepatide varied meaningfully by baseline HbA1c category in adults with overweight or obesity and type 2 diabetes in SURMOUNT-2","author":"Sattar","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajpc.2026.101445_bib0087","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0140-6736(23)01200-X","article-title":"Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"402","author":"Garvey","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2026.101445_bib0088","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0089","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0090","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","article-title":"Semaglutide in patients with obesity-related heart failure and type 2 diabetes","volume":"390","author":"Kosiborod","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0091","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jacc.2011.02.055","article-title":"Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction","volume":"58","author":"Haykowsky","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2026.101445_bib0092","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/S0140-6736(25)00509-4","article-title":"Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial","volume":"405","author":"Bonaca","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2026.101445_bib0093","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 trial of semaglutide in metabolic dysfunction\u2013associated steatohepatitis","volume":"392","author":"Sanyal Arun","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0094","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(21)01324-6","article-title":"Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial","volume":"398","author":"Rosenstock","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2026.101445_bib0095","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Fr\u00edas Juan","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0096","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(21)01443-4","article-title":"Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial","volume":"398","author":"Ludvik","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2026.101445_bib0097","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0140-6736(21)02188-7","article-title":"Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial","volume":"398","author":"Del Prato","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2026.101445_bib0098","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/jama.2022.0078","article-title":"Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: the SURPASS-5 randomized clinical trial","volume":"327","author":"Dahl","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2026.101445_bib0099","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff Ania","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0100","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMoa2410819","article-title":"Tirzepatide for obesity treatment and diabetes prevention","volume":"392","author":"Jastreboff","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0101","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1038\/s41591-023-02597-w","article-title":"Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial","volume":"29","author":"Wadden","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0102","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jama.2023.24945","article-title":"Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial","volume":"331","author":"Aronne","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2026.101445_bib0103","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa2416394","article-title":"Tirzepatide as compared with semaglutide for the treatment of obesity","volume":"393","author":"Aronne","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0104","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0106","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for Heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0107","unstructured":"Lilly Investors [Internet]. Lilly's Mounjaro (tirzepatide), a GIP\/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease. Accessed: 22 Sept, 2025 Available from: https:\/\/investor.lilly.com\/news-releases\/news-release-details\/lillys-mounjaro-tirzepatide-gipglp-1-dual-agonist-demonstrated."},{"key":"10.1016\/j.ajpc.2026.101445_bib0108","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S2213-8587(24)00102-5","article-title":"Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis","volume":"12","author":"Usman","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ajpc.2026.101445_bib0109","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1097\/00004872-199816121-00024","article-title":"Treatment with orlistat reduces cardiovascular risk in obese patients","volume":"16","author":"Zavoral","year":"1998","journal-title":"J Hypertens"},{"key":"10.1016\/j.ajpc.2026.101445_bib0110","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0140-6736(97)11509-4","article-title":"Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group","volume":"352","author":"Sj\u00f6str\u00f6m","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2026.101445_bib0111","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00431-023-05369-3","article-title":"The effect of orlistat in the treatment of non-alcoholic fatty liver in adolescents with overweight and obese","volume":"183","author":"Zahmatkesh","year":"2024","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ajpc.2026.101445_bib0112","first-page":"8326","article-title":"Significance of orlistat in management of dyslipidemia, systolic blood pressure and body mass index","volume":"26","author":"Alanazi","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.ajpc.2026.101445_bib0113","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105649","article-title":"Pharmacotherapy of obesity: An update","volume":"169","author":"Cignarella","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ajpc.2026.101445_bib0114","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/oby.2011.330","article-title":"Controlled-release phentermine\/topiramate in severely obese adults: a randomized controlled trial (EQUIP)","volume":"20","author":"Allison","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.ajpc.2026.101445_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2014.04.004","article-title":"Naltrexone\/bupropion for obesity: An investigational combination pharmacotherapy for weight loss","volume":"84","author":"Billes","year":"2014","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ajpc.2026.101445_bib0116","first-page":"751","article-title":"Naltrexone HCI\/bupropion HCI for chronic weight management in obese adults: patient selection and perspectives","volume":"10","author":"Tek","year":"2016","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.ajpc.2026.101445_bib0117","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(10)60888-4","article-title":"Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"376","author":"Greenway","year":"2010","journal-title":"Lance"},{"key":"10.1016\/j.ajpc.2026.101445_bib0118","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/oby.20309","article-title":"A randomized, phase 3 trial of naltrexone SR\/bupropion SR on weight and obesity-related risk factors (COR-II)","volume":"21","author":"Apovian","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.ajpc.2026.101445_bib0119","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.2337\/dc13-0234","article-title":"Effects of naltrexone sustained-release\/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes","volume":"36","author":"Hollander","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajpc.2026.101445_bib0120","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/oby.2010.147","article-title":"Weight loss with naltrexone SR\/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial","volume":"19","author":"Wadden","year":"2011","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.ajpc.2026.101445_bib0121","article-title":"Phentermine\/Topiramate (Qsymia) for Chronic Weight Management","author":"Gazewood","year":"2024","journal-title":"AAFP"},{"key":"10.1016\/j.ajpc.2026.101445_bib0122","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa2502081","article-title":"Coadministered cagrilintide and semaglutide in adults with overweight or obesity","volume":"393","author":"Garvey","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0123","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJMoa2505669","article-title":"Orforglipron, an oral small-molecule GLP-1 receptor agonist, in early type 2 diabetes","volume":"393","author":"Rosenstock","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0124","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/nrendo.2017.122","article-title":"Current pharmacotherapy for obesity","volume":"14","author":"Srivastava","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ajpc.2026.101445_bib0125","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00000658-195409000-00018","article-title":"An experimental evaluation of the nutritional importance of proximal and distal small intestine","volume":"140","author":"Kremen","year":"1954","journal-title":"Ann Surg"},{"key":"10.1016\/j.ajpc.2026.101445_bib0126","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0140-6736(23)00634-7","article-title":"Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial","volume":"401","author":"Verrastro","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2026.101445_bib0127","doi-asserted-by":"crossref","unstructured":"Adams TD, Davidson LE, Litwin SE, et al. Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med 377:1143-55.","DOI":"10.1056\/NEJMoa1700459"},{"key":"10.1016\/j.ajpc.2026.101445_bib0128","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1210\/jc.2004-2211","article-title":"Why do patients lose weight after Roux-en-Y gastric bypass?","volume":"90","author":"le Roux","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajpc.2026.101445_bib0129","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11695-015-1945-7","article-title":"Mechanism underlying the weight loss and complications of Roux-en-Y gastric bypass","volume":"26","author":"Abdeen","year":"2016","journal-title":"Review. Obes Surg"},{"key":"10.1016\/j.ajpc.2026.101445_bib0130","article-title":"Long-term effect of sleeve gastrectomy vs Roux-en-Y gastric bypass in people living with severe obesity: a phase III multicentre randomised controlled trial (SleeveBypass)","volume":"38","author":"Biter","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.ajpc.2026.101445_bib0131","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.53141","article-title":"Comparison of sleeve gastrectomy vs Roux-en-Y gastric bypass: a randomized clinical trial","volume":"7","author":"Hedberg","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajpc.2026.101445_bib0132","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(21)02394-1","article-title":"Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial","volume":"398","author":"Abu Dayyeh","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2026.101445_bib0133","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.soard.2012.11.011","article-title":"Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 10-year results of a prospective, randomized trial","volume":"9","author":"Angrisani","year":"2013","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.ajpc.2026.101445_bib0134","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s002689900497","article-title":"Biliopancreatic diversion","volume":"22","author":"Scopinaro","year":"1998","journal-title":"World J Surg"},{"key":"10.1016\/j.ajpc.2026.101445_bib0135","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ciresp.2021.01.008","article-title":"Experience in biliopancreatic diversion with duodenal switch: Results at 2, 5 and 10 years","volume":"100","author":"Sorribas","year":"2022","journal-title":"Cir Esp (Engl Ed)"},{"key":"10.1016\/j.ajpc.2026.101445_bib0136","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1001\/jama.292.14.1724","article-title":"Bariatric surgery: a systematic review and meta-analysis","volume":"292","author":"Buchwald","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2026.101445_bib0137","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/jama.2017.6803","article-title":"Screening for Obesity in Children and Adolescents: US Preventive Services Task Force Recommendation Statement","volume":"317","author":"Grossman","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2026.101445_bib0139","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa2407379","article-title":"Liraglutide for children 6 to <12 years of age with obesity- A randomized trial","volume":"392","author":"Fox","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0140","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1056\/NEJMoa2208601","article-title":"Once-weekly semaglutide in adolescents with obesity","volume":"387","author":"Weghuber","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0141","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1916038","article-title":"A Randomized, controlled trial of liraglutide for adolescents with obesity","volume":"382","author":"Kelly Aaron","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101445_bib0142","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1097\/AOG.0000000000003772","article-title":"Physical activity and exercise during pregnancy and the postpartum period: ACOG Committee Opinion Summary, Number 804","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajpc.2026.101445_bib0143","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ijgo.12804","article-title":"Autologous transobturator sling as an alternative therapy for stress urinary incontinence","volume":"145","author":"Laufer","year":"2019","journal-title":"Int J of Gynaecol Obstet"},{"key":"10.1016\/j.ajpc.2026.101445_bib0144","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1111\/1471-0528.15386","article-title":"Care of women with obesity in pregnancy: green-top guideline No. 72","volume":"126","author":"Denison","year":"2019","journal-title":"BJOG"},{"key":"10.1016\/j.ajpc.2026.101445_bib0145","series-title":"Committee to Reexamine IOM Pregnancy Weight Guidelines. Weight Gain during pregnancy: reexamining the guidelines","year":"2009"},{"key":"10.1016\/j.ajpc.2026.101445_bib0146","unstructured":"National Institute for Health and Care Excellence. PH27: Weight management before, during and after pregnancy 2010. Available from: https:\/\/www.nice.org.uk\/guidance\/ph27."},{"key":"10.1016\/j.ajpc.2026.101445_bib0147","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.jogc.2018.04.003","article-title":"Risk of thromboembolic disease with cost estimates in patients undergoing robotic assisted surgery for endometrial cancer and review of the literature","volume":"40","author":"Laskov","year":"2018","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ajpc.2026.101445_bib0148","first-page":"S295","article-title":"Diabetes Care in the hospital: standards of care in diabetes-2024","volume":"47","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajpc.2026.101445_bib0149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.14.S1.1","volume":"14","author":"Mechanick","year":"2008","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ajpc.2026.101445_bib0150","doi-asserted-by":"crossref","DOI":"10.2196\/40589","article-title":"Applications of artificial intelligence to obesity research: scoping review of methodologies","volume":"24","author":"An","year":"2022","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.ajpc.2026.101445_bib0151","article-title":"Visualization obesity risk prediction system based on machine learning","volume":"14","author":"Du","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpc.2026.101445_bib0152","doi-asserted-by":"crossref","first-page":"E797E809","DOI":"10.1503\/cmaj.250502","article-title":"Pharmacotherapy for obesity management in adults: 2025 clinical practice guideline update","volume":"197","author":"Pedersen","year":"2025","journal-title":"CMAJ"},{"key":"10.1016\/j.ajpc.2026.101445_bib0153","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4081\/cardio.2025.68","article-title":"The Global Implementation Guidelines Initiative: how to optimize cardiorenalmetabolic care worldwide","volume":"3","author":"Pinto","year":"2025","journal-title":"Global Cardiology"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726000395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726000395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:22:37Z","timestamp":1789039357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667726000395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":152,"alternative-id":["S2666667726000395"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101445","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"iCARDIO Alliance global implementation guidelines for the management of obesity 2025 focus on prevention and treatment of cardiometabolic disease","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101445","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101445"}}